About this trial
Air pollution and microplastics pose major public health threats. Emerging data have shown that micro- and nanoplastics (MNPs) are ubiquitous environmental pollutants accumulating in human tissues, triggering inflammation and prothrombotic state. This study will investigate the presence and burden of MNPs within coronary thrombi/thromboaspirate of patients presenting with ST segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention and their association with cardiac damage, plaque vulnerability, microvascular obstruction, and cardiovascular events. Plaque vulnerability will be explored by optical coherence tomography, while microvascular obstruction will be assessed by bolus thermodilution and cardiac magnetic resonance. Participants will be followed up for 1-year to evaluate whether the presence and the burden of MNPs will be associated with a higher incidence of the cardiovascular events.
Eligibility criteria
Qualifiers
Age > 18 years old;
STEMI undergoing urgent invasive coronary angiography;
Acute thrombotic coronary occlusion/sub-occlusion (TIMI 0/1);
Clinical indication to thromboaspiration;
Disqualifiers
Contraindications to percutaneous coronary intervention;
Hemodynamic instability or cardiogenic shock;
End-stage chronic kidney disease;
Life expectancy < 1 year due to non-cardiac pathology.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Azienda Ospedaliera "Sant'Andrea"
Lead sponsor
University of Campania Luigi Vanvitelli
Collaborator
Azienda Ospedaliera Universitaria Integrata Verona
Collaborator
Morgagni Pierantoni Hospital
Collaborator
Azienda Ospedaliera Sant'Anna e San Sebastiano
Collaborator
University Hospital, Catania
Collaborator
A.O.U. Città della Salute e della Scienza - Molinette Hospital
Collaborator
Niguarda Hospital
Collaborator
Azienda Ospedaliera Universitaria Ferrara
Collaborator